Acurx Pharmaceuticals, Inc.
NASDAQ:ACXP
0.3728 (USD) • At close April 17, 2025
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|---|
| Assets: | ||||||
| Current Assets: | ||||||
| Cash & Cash Equivalents
| 3.707 | 7.474 | 9.112 | 12.959 | 3.175 | 2.483 |
| Short Term Investments
| 0 | 0 | 0 | 0 | 0 | 0 |
| Cash and Short Term Investments
| 3.707 | 7.474 | 9.112 | 12.959 | 3.175 | 2.483 |
| Net Receivables
| 0.051 | 0.129 | 0 | 0 | 0 | 0 |
| Inventory
| 0 | 0 | 0 | 0 | 0 | 0 |
| Other Current Assets
| 0 | 0.106 | 0.265 | 0.295 | 0.049 | 0.048 |
| Total Current Assets
| 3.858 | 7.709 | 9.377 | 13.254 | 3.224 | 2.531 |
| Non-Current Assets: | ||||||
| Property, Plant & Equipment, Net
| 0 | 0 | 0 | 0 | 0 | 0 |
| Goodwill
| 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets
| 0 | 0 | 0 | 0 | 0 | 0 |
| Goodwill and Intangible Assets
| 0 | 0 | 0 | 0 | 0 | 0 |
| Long Term Investments
| 0 | 0 | 0 | 0 | 0 | 0 |
| Tax Assets
| 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets
| 0 | 0 | 0 | 0 | 0 | 0 |
| Total Non-Current Assets
| 3,854.105 | 0 | 0 | 0 | 0 | 0 |
| Total Assets
| 3,857.963 | 7.709 | 9.377 | 13.254 | 3.224 | 2.531 |
| Liabilities & Equity: | ||||||
| Current Liabilities: | ||||||
| Account Payables
| 0 | 0 | 0.03 | 0.063 | 0 | 0.002 |
| Short Term Debt
| 0 | 0 | 0 | 0 | 0.017 | 0 |
| Tax Payables
| 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue
| 0 | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities
| 3,242.842 | 3.042 | 2.032 | 0.781 | 0.456 | 1.709 |
| Total Current Liabilities
| 3,242.842 | 3.042 | 2.062 | 0.844 | 0.473 | 1.712 |
| Non-Current Liabilities: | ||||||
| Long Term Debt
| 0 | 0 | 0 | 0 | 0.05 | 0 |
| Deferred Revenue Non-Current
| 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Tax Liabilities Non-Current
| 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities
| 0 | 0 | 0 | 0 | 0 | 0 |
| Total Non-Current Liabilities
| 0 | 0 | 2.062 | 0 | 0.05 | 0 |
| Total Liabilities
| 3,242.842 | 3.042 | 2.062 | 0.844 | 0.522 | 1.712 |
| Equity: | ||||||
| Preferred Stock
| 0 | 0 | 0 | 0 | 0 | 0 |
| Common Stock
| 0.017 | 0.014 | 0.012 | 0.01 | 16.502 | 10.02 |
| Retained Earnings
| -67,321.956 | -53.219 | -38.641 | -26.548 | -13.801 | -9.201 |
| Accumulated Other Comprehensive Income/Loss
| 0 | 0 | -38.641 | -26.548 | -13.801 | -9.201 |
| Other Total Stockholders Equity
| 67,937.06 | 57.871 | 84.586 | 38.948 | 13.801 | 9.201 |
| Total Shareholders Equity
| 615.121 | 4.667 | 7.315 | 12.41 | 2.702 | 0.82 |
| Total Equity
| 615.121 | 4.667 | 7.315 | 12.41 | 2.702 | 0.82 |
| Total Liabilities & Shareholders Equity
| 3,857.963 | 7.709 | 9.377 | 13.254 | 3.224 | 2.531 |